These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10611136)

  • 1. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED; Hankins DC; Taraday JK
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose disulfiram does not inhibit CYP2A6 activity.
    Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
    Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4.
    Kharasch ED; Hankins DC; Fenstamaker K; Cox K
    Eur J Clin Pharmacol; 2000; 55(11-12):853-9. PubMed ID: 10805064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
    Sellers EM; Kaplan HL; Tyndale RF
    Clin Pharmacol Ther; 2000 Jul; 68(1):35-43. PubMed ID: 10945314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic interactions of methoxsalen and coumarin in humans and mice.
    Mäenpää J; Juvonen R; Raunio H; Rautio A; Pelkonen O
    Biochem Pharmacol; 1994 Oct; 48(7):1363-9. PubMed ID: 7945434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
    Peamkrasatam S; Sriwatanakul K; Kiyotani K; Fujieda M; Yamazaki H; Kamataki T; Yoovathaworn K
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):475-84. PubMed ID: 17220563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
    Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
    Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
    Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
    Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of coumarin metabolism in Turkish population.
    Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.
    Pasanen M; Rannala Z; Tooming A; Sotaniemi EA; Pelkonen O; Rautio A
    Toxicology; 1997 Dec; 123(3):177-84. PubMed ID: 9355936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.
    Sellers EM; Ramamoorthy Y; Zeman MV; Djordjevic MV; Tyndale RF
    Nicotine Tob Res; 2003 Dec; 5(6):891-9. PubMed ID: 14668073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2A6: a human coumarin 7-hydroxylase.
    Pelkonen O; Rautio A; Raunio H; Pasanen M
    Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
    Li Y; Li NY; Sellers EM
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumption of watercress fails to alter coumarin metabolism in humans.
    Murphy SE; Johnson LM; Losey LM; Carmella SG; Hecht SS
    Drug Metab Dispos; 2001 Jun; 29(6):786-8. PubMed ID: 11353744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic polymorphism of CYP2A6 activity in a Chinese population.
    Xu P; Huang SL; Zhu RH; Han XM; Zhou HH
    Eur J Clin Pharmacol; 2002 Aug; 58(5):333-7. PubMed ID: 12185557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.
    Liu C; Zhuo X; Gonzalez FJ; Ding X
    Mol Pharmacol; 1996 Oct; 50(4):781-8. PubMed ID: 8863822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringenin and interindividual variability in interaction of coumarin with grapefruit juice.
    Bourian M; Runkel M; Krisp A; Tegtmeier M; Freudenstein J; Legrum W
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):289-93. PubMed ID: 10445384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin and CYP2A6 activity in healthy subjects.
    Asimus S; Hai TN; Van Huong N; Ashton M
    Eur J Clin Pharmacol; 2008 Mar; 64(3):283-92. PubMed ID: 18064444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.